Cargando…

From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes

BACKGROUND: Findings from randomised control trials inform the development of evidence-based eating disorder (ED) practice guidelines internationally. Only recently are data beginning to emerge regarding how these treatments perform outside of research settings. This study aimed to evaluate treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Simic, Mima, Stewart, Catherine S., Konstantellou, Anna, Hodsoll, John, Eisler, Ivan, Baudinet, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862310/
https://www.ncbi.nlm.nih.gov/pubmed/35189967
http://dx.doi.org/10.1186/s40337-022-00553-6
_version_ 1784655030617374720
author Simic, Mima
Stewart, Catherine S.
Konstantellou, Anna
Hodsoll, John
Eisler, Ivan
Baudinet, Julian
author_facet Simic, Mima
Stewart, Catherine S.
Konstantellou, Anna
Hodsoll, John
Eisler, Ivan
Baudinet, Julian
author_sort Simic, Mima
collection PubMed
description BACKGROUND: Findings from randomised control trials inform the development of evidence-based eating disorder (ED) practice guidelines internationally. Only recently are data beginning to emerge regarding how these treatments perform outside of research settings. This study aimed to evaluate treatment pathways and outcomes for a specialist child and adolescent ED service across a five-year period. METHODS: All consecutive referrals between August 2009 and January 2014 seen at the Maudsley Centre for Child and Adolescent Eating Disorders in London were included. Data are reported on for all young people who were offered treatment (N = 357). RESULTS: Most young people referred to the service were diagnosed with anorexia nervosa (AN)/Atypical AN (81%). Treatment for AN/Atypical AN (median 11 months) was predominantly ED focused family therapy (99%). Treatment for bulimia nervosa (BN)/Atypical BN (median seven months) was most commonly a combination of cognitive behavioural therapy and ED focused family therapy (87%). At discharge, 77% of the AN/Atypical AN group had a good or intermediate outcome and 59% of the BN/Atypical BN group reported no or fewer than weekly bulimic episodes. 27% of the AN/Atypical AN group had enhanced treatment with either day- and/or inpatient admissions (AIM group). The %mBMI at 3 months of treatment was strongest predictor of the need for treatment enhancement and more modestly EDE-Q and age at assessment. The AIM group at assessment had significantly lower weight, and higher ED and comorbid symptomatology and went on to have significantly longer treatment (16 vs. 10 months). At discharge, this group had significantly fewer good and more poor outcomes on the Morgan Russell criteria, but similar outcomes regarding ED and comorbid symptoms and quality of life. When analysis was adjusted for %mBMI at assessment, 1 and 3 months of treatment, differences in Morgan Russell outcomes and %mBMI were small and compatible with no difference in outcome by treatment group. CONCLUSIONS: This study shows that outcomes in routine clinical practice in a specialist community-based service compare well to those reported in research trials. The finding from research trials that early weight gain is associated with improved outcomes was also replicated in this study. Enhancing outpatient treatment with day treatment and/or inpatient care is associated with favourable outcome for most of the young people, although a longer duration of treatment is required. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40337-022-00553-6.
format Online
Article
Text
id pubmed-8862310
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88623102022-02-23 From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes Simic, Mima Stewart, Catherine S. Konstantellou, Anna Hodsoll, John Eisler, Ivan Baudinet, Julian J Eat Disord Research Article BACKGROUND: Findings from randomised control trials inform the development of evidence-based eating disorder (ED) practice guidelines internationally. Only recently are data beginning to emerge regarding how these treatments perform outside of research settings. This study aimed to evaluate treatment pathways and outcomes for a specialist child and adolescent ED service across a five-year period. METHODS: All consecutive referrals between August 2009 and January 2014 seen at the Maudsley Centre for Child and Adolescent Eating Disorders in London were included. Data are reported on for all young people who were offered treatment (N = 357). RESULTS: Most young people referred to the service were diagnosed with anorexia nervosa (AN)/Atypical AN (81%). Treatment for AN/Atypical AN (median 11 months) was predominantly ED focused family therapy (99%). Treatment for bulimia nervosa (BN)/Atypical BN (median seven months) was most commonly a combination of cognitive behavioural therapy and ED focused family therapy (87%). At discharge, 77% of the AN/Atypical AN group had a good or intermediate outcome and 59% of the BN/Atypical BN group reported no or fewer than weekly bulimic episodes. 27% of the AN/Atypical AN group had enhanced treatment with either day- and/or inpatient admissions (AIM group). The %mBMI at 3 months of treatment was strongest predictor of the need for treatment enhancement and more modestly EDE-Q and age at assessment. The AIM group at assessment had significantly lower weight, and higher ED and comorbid symptomatology and went on to have significantly longer treatment (16 vs. 10 months). At discharge, this group had significantly fewer good and more poor outcomes on the Morgan Russell criteria, but similar outcomes regarding ED and comorbid symptoms and quality of life. When analysis was adjusted for %mBMI at assessment, 1 and 3 months of treatment, differences in Morgan Russell outcomes and %mBMI were small and compatible with no difference in outcome by treatment group. CONCLUSIONS: This study shows that outcomes in routine clinical practice in a specialist community-based service compare well to those reported in research trials. The finding from research trials that early weight gain is associated with improved outcomes was also replicated in this study. Enhancing outpatient treatment with day treatment and/or inpatient care is associated with favourable outcome for most of the young people, although a longer duration of treatment is required. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40337-022-00553-6. BioMed Central 2022-02-21 /pmc/articles/PMC8862310/ /pubmed/35189967 http://dx.doi.org/10.1186/s40337-022-00553-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Simic, Mima
Stewart, Catherine S.
Konstantellou, Anna
Hodsoll, John
Eisler, Ivan
Baudinet, Julian
From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes
title From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes
title_full From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes
title_fullStr From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes
title_full_unstemmed From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes
title_short From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes
title_sort from efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862310/
https://www.ncbi.nlm.nih.gov/pubmed/35189967
http://dx.doi.org/10.1186/s40337-022-00553-6
work_keys_str_mv AT simicmima fromefficacytoeffectivenesschildandadolescenteatingdisordertreatmentsintherealworldpart1treatmentcourseandoutcomes
AT stewartcatherines fromefficacytoeffectivenesschildandadolescenteatingdisordertreatmentsintherealworldpart1treatmentcourseandoutcomes
AT konstantellouanna fromefficacytoeffectivenesschildandadolescenteatingdisordertreatmentsintherealworldpart1treatmentcourseandoutcomes
AT hodsolljohn fromefficacytoeffectivenesschildandadolescenteatingdisordertreatmentsintherealworldpart1treatmentcourseandoutcomes
AT eislerivan fromefficacytoeffectivenesschildandadolescenteatingdisordertreatmentsintherealworldpart1treatmentcourseandoutcomes
AT baudinetjulian fromefficacytoeffectivenesschildandadolescenteatingdisordertreatmentsintherealworldpart1treatmentcourseandoutcomes